Back to School: How biopharma can reboot drug development. Access exclusive analysis here

IDEC-C2B8: Began a Phase II trial

IDEC Pharmaceuticals Corp. (IDPH), San Diego, Calif.
Product: IDEC-C2B8

Read the full 92 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE